)
Edge17 Apr 2026
The New York Times Company: Adapting to the Times
How The New York Times Company built on a century-long legacy of trusted journalism to navigate disruption and reshape its business model.
ProKidney
ProKidney (PROK) investor relations material
ProKidney Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary17 Apr, 2026
Executive summary
Annual meeting scheduled for May 28, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 27, 2026.
Voting matters and shareholder proposals
Election of three directors: William F. Doyle, Alan M. Lotvin, M.D., and Brian J.G. Pereira, M.D., with board recommending a vote for each.
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.
Proxyholders authorized to vote on other business that may arise at the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from ProKidney
- Director elections, auditor ratification, and governance reforms headline the annual meeting.PROK
Proxy filing17 Apr 2026 - FDA alignment, strong clinical progress, and cash runway into 2027 despite ongoing losses.PROKQ4 202518 Mar 2026
- Rilparencel stabilized kidney function for 18 months in advanced diabetic CKD with no serious adverse events.PROKStudy Update2 Feb 2026
- Phase II data show kidney function stabilization; U.S. phase III focus aims for faster, cost-effective progress.PROKMorgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026
- Phase III trial of rilparencel targets advanced CKD, with pivotal data expected in 2027.PROKUBS Virtual Organ Restoration and Cell Therapy Day19 Jan 2026
- Pivotal Phase III trial of rilparencel for advanced CKD targets Q2 2027 readout, with strong phase II results.PROK44th Annual J.P. Morgan Healthcare Conference14 Jan 2026
- Rilparencel shows strong efficacy and safety in CKD, with phase 3 results expected in 2027.PROKCorporate presentation14 Jan 2026
- Phase III kidney cell therapy program advances with FDA support for accelerated approval.PROKGuggenheim’s Inaugural Healthcare Innovation Conference14 Jan 2026
- FDA supports a single pivotal trial for rilparencel, with key data and milestones expected in 2024.PROKJefferies London Healthcare Conference 202413 Jan 2026
Next ProKidney earnings date
Q1 20268 May, 2026
ProKidney
Next ProKidney earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage